Quince Therapeutics (QNCX) reported a net loss of $75.5 million, or $12.31 per basic and diluted share, for the second quarter ended June 30, 2026. The company reported $116 million in cash and cash equivalents at quarter-end.
During the quarter, Quince completed its acquisition of Orphai Therapeutics and closed a private placement with $115 million in gross upfront proceeds. The acquisition added inhaled rapamycin candidate LAM-001 to Quince's pipeline for pulmonary diseases.
- R&D expense was $5.5 million, compared with $6.6 million a year earlier.
- G&A expense was $16.6 million, compared with $3.3 million in the prior-year period.
- Cash is expected to fund operations through the end of 2028.
- LAM-001 Phase 2 BOS data are expected in the first quarter of 2027, while Phase 2b PH-ILD data are anticipated in the first quarter of 2028.
- Quince had 978,022 common shares outstanding as of June 30, 2026.
$QNCX Hedge Fund Activity
We have seen 11 institutional investors add shares of $QNCX stock to their portfolio, and 58 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NANTAHALA CAPITAL MANAGEMENT, LLC removed 2,672,429 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $270,984
- WOODLINE PARTNERS LP removed 1,421,542 shares (-73.2%) from their portfolio in Q1 2026, for an estimated $144,144
- MILLENNIUM MANAGEMENT LLC removed 939,980 shares (-79.0%) from their portfolio in Q1 2026, for an estimated $95,313
- ALMITAS CAPITAL LLC removed 930,134 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $94,315
- SUPERSTRING CAPITAL MANAGEMENT LP removed 858,711 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $17,414,659
- IEQ CAPITAL, LLC removed 600,105 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $10,915,909
- RENAISSANCE TECHNOLOGIES LLC removed 538,100 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $10,912,668
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
